DOCSLIB.ORG

Riding the Wave of the 16Th ANGIOPLASTY SUMMIT TCTAP 2011

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

2011 Riding the Wave of TCTAP the 16th ANGIOPLASTY SUMMIT TCTAP 2011 ANGIOPLASTY SUMMIT Course Directors Course Co-Directors Scientific Committee Seung-Jung Park, MD Cheol Whan Lee, MD Maurice Buchbinder, MD Nae Hee Lee, MD Seong-Wook Park, MD Young-Hak Kim, MD So-Yeon Choi, MD Tae-Hwan Lim, MD Ki Bae Seung, MD Seung-Whan Lee, MD Wook Sung Chung, MD Yean-Leng Lim, MD Myeong-Ki Hong, MD Antonio Colombo, MD Hyeon-Cheol Gwon, MD Jeffrey W. Moses, MD Martin B. Leon, MD Jean Fajadet, MD Yaling Han, MD Dong Joo Oh, MD Gregg W. Stone, MD Rulin Gao, MD Mun Kyung Hong, MD Duk-Woo Park, MD Gary S. Mintz, MD Junbo Ge, MD Yong Huo, MD Seung-Woon Rha, MD Eberhard Grube, MD Seung-Ho Hur, MD Teguh Santoso, MD Ik-Kyung Jang, MD Yangsoo Jang, MD Eak-Kyun Shin, MD Osamu Katoh, MD Myung-Ho Jeong, MD Kui-Hian Sim, MD John R. Laird, Jr, MD Hyo-Soo Kim, MD Tetsu Yamaguchi, MD Shigeru Saito, MD Jae-Joong Kim, MD Joo-Young Yang, MD Patrick W. Serruys, MD June Hong Kim, MD Junghan Yoon, MD Takahiko Suzuki, MD Kwon-Bae Kim, MD Robaayah Zambahari, MD Alan C. Yeung, MD Seong-Ho Kim, MD Yong Huo, MD Young Jo Kim, MD Jae-Ki Ko, MD Michael Kang-Yin Lee, MD Discovering New Paradigm... ANGIOPLASTY SUMMIT ANGIOPLASTY SUMMIT-TCTAP IS ONE OF THE LARGEST EDUCATIONAL SYMPOSIUMS IN ASIA PACIFIC SPECIALIZING IN INTERVENTIONAL CARDIOVASCULAR MEDICINE. FOR THE PREVIOUS 15 YEARS, TCTAP HAS TCTAP GROWN UP DRAMATICALLY, AND IT HAS PLAYED A SIGNIFICANT ROLE AS A LEADING PLAYER IN THIS FIELD THROUGHOUT CREATING EDUCATIONAL CONTENT AND PRESENTING THE LATEST ADVANCES IN CURRENT 2011 THERAPIES AND CLINICAL RESEARCH. Learning Objectives Associations and Affiliations Review the latest basic and clinical investigations to guide how to CardioVascular Research Foundation (CVRF)/ Asan Medical Center, manage optimally the patients with vascular or structural heart Seoul, Korea disease Cardiovascular Research Foundation (CRF) / Columbia University Integrate the newest interventional techniques and devices related Medical Center, New York, USA to patient care in the coronary, peripheral and carotid arteries, and Transcatheter Cardiovascular Therapeutics (TCT), USA structural heart disease The Paris Course on Revascularization (EuroPCR), Europe Compare and contrast different approaches to treat the same type of lesion, and apply an optimal treatment to various patients in their ACC i2 Summit, USA clinical practice Asian Pacific Society of Interventional Cardiology (APSIC), Asia Learn numerous treatment strategies through reviewing diverse Pacific challenging cases submitted from all around the world and CardioAlex PanArab, Egypt discussing with the world renowned experts China Interventional Therapeutics (CIT), China Integrate adjunctive pharmacologic management in treating patients with cardiovascular disease and patients underwent intervention Chinese Society of Cardiology (CSC), China therapies Complex Catheter Therapeutics (CCT), Japan Congress of Intervention Cardiology in Hanoi, Vietnam Target Attendees INDIA LIVE, India Interventional cardiologists Japanese Association of Cardiovascular Intervention and General cardiologists Therapeutics (CVIT), Japan Physicians interested in cardiology and vascular medicine MYLIVE, Malaysia Radiologists Sendai / New Tokyo Live, Japan Basic scientists Taiwan Transcatheter Therapeutics (TTT), Taiwan Vascular medicine specialists The Society for Cardiovacular Angiography and Interventions (SCAI), USA Vascular surgeons World Congress of Cardiology (WCC) Cardiac surgeons The Korean Society of Cardiology Interventional pediatricians The Korean Society of Cardiovascular Imaging (KOSCI) Nurses and technologists The Korean Society of Interventional Cardiology Other health care professionals with special interest in the interventional vascular therapy and medicine The Korean Study Group of Pediatric Interventional Cardiology Korean Association of Cardiovascular and Pulmonary Rehabilitation Program Sponsorship and Support (KACPR) Cardiovascular Technology Association (CTA) ANGIOPLASTY SUMMIT-TCTAP is sponsored by CardioVascular Research Foundation (CVRF) and partially funded by educational grants from commercial supporters. ANGIOPLASTY SUMMIT-TCTAP 2011 3 ANGIOPLASTY SUMMITTCTAP 2011 Meeting at a Glance Official Language: English Simultaneous Translation: Chinese, Japanese and Korean Tuesday, April 26 Town Hall Meeting Tutorial Arena Fellowship Training Course CSC Session Wednesday, April 27 Breakfast Lunchtime Meetings Activities Evening Symposia with Dinner Main Arena TCT AP Session : Live Cases & Featured Lectures Live Cases & Plenary Sessions coronary coronary Coronary Arena session #1 session #2 Coronary: Live Cases (TAVI) (ACS) Endovascular Arena Endovascular: Live Cases & State-of-the-Art Lectures Ida I (Abstract) Moderated Abstracts & Cases Presentations Ida II (Case) Moderated Complex Case Competition Exhibit Exhibit Thursday, April 28 Breakfast Lunchtime Evening Symposia with Dinner Meetings Activities Main Arena Live Cases Late-Breaking Live Cases & Plenary Sessions Live Cases & Plenary Sessions CCT Session : ACC i2 Session: EuroPCR Session : Coronary: Coronary Arena Left Main & Bifurcation Summit Coronary: Live Cases CTO ACS Bifurcation Live Cases Endovascular Arena Live Cases & Endovascular Sessions Structural Heart Disease Symposium : Live Cases & Lectures Tutorial Arena Most Distinguished Studies 2010-2011 : Meet the Authors and Disuss with the Experts Imaging Workshop Ida I (Abstract) Moderated Abstract Competition Moderated Abstract Competition Ida II (Case) Moderated Complex Case Competition Moderated Complex Case Competition Exhibit Exhibit Friday, April 29 Breakfast Meetings th Main Arena th 14 Annual Conference for Cardiovascular 5 Cardiopulmonary Rehabilitation Workshop Nurse & Technologist (with Lunch) Coronary Arena Challenging Case Competition with Experts' Review Endovascular Arena Challenging Case Competition with Experts' Review Exhibit Exhibit ANGIOPLASTY SUMMIT TCTAP HIGHLIGHTS with What's New New! MEET THE EXPERTS OVER BREAKFAST New! MEET THE AUTHORS Most Distinguished Studies 2010-2011: Meet the Authors TCTAP “Enjoy your morning hours and get something useful!!” and discuss with the experts. “The Best Collection of Publications in the Interventional and Current Issues in the Cardiovascular & Endovascular 2011 Clinical Cardiology Presented by Primary Investigators for Interventional Field: Focus Reviews, Case Presentations and Each Study” Discussion in a small group environment LATE-BREAKING CLINICAL TRIALS 17 KEY TOPICS to cover TRANSCATHETER VALVE THERAPIES - Percutaneous Valve Therapy: "Current and More" th - Vulnerable Plaque: The Challenges Ahead 5 LEFT MAIN & BIRFURCATION SUMMIT - Role of Noninvasive CT Imaging in Daily Practice: “The Roadmap of Treatment for Left Main Disease and A Case-Based Approach Bifurcation Lesions” - Bifurcation Intervention: "Optimizing Stenting Technique" New! TECHNOLOGY AND INNOVATION - Evolving Antiplatelet Therapy: "New Pharmaclogic Options Town Hall Meeting: How to Innovate in CV Technology for ACS and PCI Patients" “Moving in New Directions; Emerging New Technology and Innovation in CV Field Introduced by Industry - Revascularization Strategies in Diabetic Patients: Representatives and Physicians Together” "Diabetic Paradox: Is It Real?" New! FELLOWS COURSE - Left Main Stenting: "Evidence vs. Out of Evidence" Half-Day Fellowship Training Course from “A” to “Z” - Drug-coated Stent or Balloon for PVD: - Chinese & English Translation Available "New Horizon for PVD" INTERNATIONAL MEETINGS - Pharmacogenomics and Platelet Reactivity Test AND SOCIETIES @ TCTAP - STEMI Now: Same Story, Different Tales ACCi2 & CRF - Innovations in 2011: Now and the Future TCT: TAVI Revolution, DES Dilemmas - Carotid Stenting: "Best Licence for Carotid Imaging & FFR Controversies Revascularization" “Hot” New Therapies - OCT : "The 2nd Generation OCT Is Useful to Assess EuroPCR: Bifurcation Complex Coronary Lesions" APSIC & CIT: Left Main & Bifurcation Summit - Revascularization for Multivessel Coronary Disease: CCT: Complex CTO interventions "Complete Revascularization: The Link Between Anatomy New! Chinese Society of Cardiology (CSC) and Function" - Chinese & English Translation Available - Paradigm Shift to "Functional Angioplasty" - Techniques for CTO Intervention: "Best Selection and Right Direction" - New DES Technologies ANGIOPLASTY SUMMIT-TCTAP 2011 5 PROGRAM OVERVIEW 2011 TCTAP APRIL 26, TUESDAY APRIL 27, WEDNESDAY Technology and Innovation Meet the Experts over Breakfast! TCTAP Session co-organized by CVRF (Seoul, Korea) and Town Hall Meeting: How to Innovate in CV - Percutaneous Valve Therapy: CRF (New York, USA) Technology “Moving in New Directions; "Current and More" ANGIOPLASTY SUMMIT - TAVI Revolution Emerging New Technology and Innovation - STEMI Now: Same Story, Different Tales in CV Field Introduced by Industry - DES Dilemmas - Role of Noninvasive CT Imaging in Daily Representatives and Physicians Together” - Imaging & FFR Controversies Practice: A Case-Based Approach - “Hot” New Therapies Fellows Course - Bifurcation Intervention: "Optimizing Half-Day Fellowship Training Course from Stenting Technique" Main Sessions “A” to “Z” - Evolving Antiplatelet Therapy: "New - Paradigm Shift for PCI - Chinese & English Translation Available Pharmaclogic Options for ACS and PCI - Unsolved Issues; Evidence Based Patients" CSC @TCTAP Approach - Revascularization Strategies in Diabetic A First-Time Program co-organized by Patients: "Diabetic Paradox: Is It Real?" Coronary Sessions Chinese Society of Cardiology
Recommended publications
  • Comparison of the Treatment Practice And

    Comparison of the Treatment Practice And

    RESEARCH ARTICLE Comparison of the treatment practice and hospitalization cost of percutaneous coronary intervention between a teaching hospital and a general hospital in Malaysia: A cross sectional study Kun Yun Lee1*, Wan Azman Wan Ahmad2, Ee Vien Low3, Siow Yen Liau4,5, a1111111111 Lawrence Anchah6, Syuhada Hamzah7, Houng-Bang Liew5,8, Rosli B. Mohd Ali9, a1111111111 Omar Ismail10, Tiong Kiam Ong11, Mas Ayu Said1, Maznah Dahlui1 a1111111111 a1111111111 1 Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia, 2 Division of Cardiology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala a1111111111 Lumpur, Malaysia, 3 Pharmaceutical Services Division, Ministry of Health, Selangor, Malaysia, 4 Department of Pharmacy, Queen Elizabeth 2 Hospital, Sabah, Malaysia, 5 Clinical Research Centre, Queen Elizabeth 2 Hospital, Sabah, Malaysia, 6 Department of Pharmacy, Sarawak General Hospital Heart Centre, Sarawak, Malaysia, 7 Administrative Office, Penang General Hospital, Penang, Malaysia, 8 Division of Cardiology, Queen Elizabeth 2 Hospital, Sabah, Malaysia, 9 Department of Cardiology, National Heart Institute, Kuala Lumpur, Malaysia, 10 Division of Cardiology, Penang General Hospital, Penang, Malaysia, 11 Department of OPEN ACCESS Cardiology, Sarawak General Hospital Heart Centre, Sarawak, Malaysia Citation: Lee KY, Wan Ahmad WA, Low EV, Liau SY, Anchah L, Hamzah S, et al. (2017) Comparison * [email protected] of the treatment practice and hospitalization cost of percutaneous coronary intervention between a teaching hospital and a general hospital in Abstract Malaysia: A cross sectional study. PLoS ONE 12 (9): e0184410. https://doi.org/10.1371/journal. pone.0184410 Editor: Yoshihiro Fukumoto, Kurume University Introduction School of Medicine, JAPAN The increasing disease burden of coronary artery disease (CAD) calls for sustainable car- Received: May 15, 2017 diac service.
  • 300512 CPG Management of Stroke Copy

    300512 CPG Management of Stroke Copy

    I CLINICAL PRACTICE GUIDELINES DEVELOPMENT GROUP AUTHORS (in alphabetical order) PROF DR HAMIDON BASRI Consultant Neurologist Chairperson University Putra Malaysia, Selangor A/PROF DR CHIN SZE PIAW Consultant Cardiologist International Medical University, KL DR LOOI IRENE Consultant Neurologist Hospital Seberang Jaya, Penang DR MAK CHOON SOON Consultant Neurologist Gleneagles Hospital, KL A/PROF DR MOHAMED SOBRI MUDA Consultant Neuroradiologist University Kebangsaan Malaysia Medical Centre, KL DATO’ DR MD. HANIP RAFIA Consultant Neurologist Hospital Kuala Lumpur, KL PROF DR TAN KAY SIN Consultant Neurologist University Malaya Medical Centre, KL DR ZARIAH ABDUL AZIZ Consultant Neurologist Hospital Sultanah Nur Zahirah, Terengganu EXTERNAL REVIEWERS (in alphabetical order) DR HJ BAHANORDIN BIN JAAFAR Physician of Rehabilitation Medicine Hospital Serdang, Selangor PROF DR GOH KHEAN JIN Consultant Neurologist University Malaya Medical Centre, KL DATO’ DR LOH THIAM GHEE Consultant Neurologist Sime Darby Medical Centre, Selangor DATO’ DR MOHD RANI JUSOH Consultant Neurologist Ampang Puteri Hospital, KL DATO’ DR MUHAMMAD RADZI BIN ABU HASSAN Consultant Physician Hospital Sultanah Bahiyah, Kedah ASSOC PROF DR NOOR AZAH ABD AZIZ Family Medicine Specialist University Kebangsaan Malaysia Medical Center, KL PROF DATO’ DR RAYMOND AZMAN ALI Consultant Neurologist University Kebangsaan Malaysia Medical Centre, KL PROF DR TAN CHONG TIN Consultant Neurologist University Malaya Medical Centre, KL II RATIONALE AND PROCESS OF GUIDELINE DEVELOPMENT Rationale Stroke is a leading cause of death and disability in Malaysia. Thus, guidelines on the management are imperative to ensure best available therapy is instituted. The clinical practice guidelines (CPG) on ischaemic stroke was developed to provide clear and concise approach to all clinicians on the current concepts in the management of ischaemic stroke patients.
  • Journal of the ASEAN Federation of Endocrine Societies

    Journal of the ASEAN Federation of Endocrine Societies

    Journal of the JournalASEAN of the Federation of ASEANEndocrine Federation Societies of EndocrineVolume No. 34 Special EditionSocieties | ISSN 2308-118x (Online) Vol. 32 No. 2 November 2017 | ISSN 0857-1074 | eISSN 2308-118x 2019 1| 0 Pre-Congress: 18 July 2019 Congress: 19 - 21 July 2019 Hilton & Le Méridien Kuala Lumpur, Malaysia The Journal of the ASEAN Federation of Endocrine Societies (JAFES) is an open-access, peer-reviewed, English language, medical and health science journal that is published two times a year by the ASEAN Federation of Endocrine Societies (AFES). Its editorial policies are aligned with the policies of the International Committtee of Medical Journal Editors (www.icmje.org). SIMPLIFYING THE COMPLEXITY OF ENDOCRINOLOGY JAFES welcomes manuscripts on all aspects of endocrinology and metabolism in the form of original articles, review articles, case reports, feature articles (clinical practice guidelines, clinical case seminars, clinical practice guidelines, book reviews, et cetera), editorials, letters to the Editor, brief communications and special announcements. Authors may include members and non-members of the AFES. Authors are required to accomplish, sign and submit scanned copies of the JAFES Author Form consisting of:Messages (1) Authorship Certification, that the manuscript has been read and approved by all authors, and that the requirements for authorship have been met by each Organisingauthor; (2) the Author Declaration & Scientific, that the article Committee represents original material that is not being considered for publication or has not been published or accepted for publication elsewhere; (3) the Statement of Copyright Transfer [accepted manuscripts become the permanent property of the JAFES and are licensed Listwith an ofAttribution Faculty-Share Alike-Non-Commercial Creative Commons License.
  • CRM-Bulletin-Issue-07

    CRM-Bulletin-Issue-07

    By Clinical Research Malaysia ISSUE of Clinical Research and Therapy 07 DRIVERS OF CHANGE IN ENDOCRINOLOGY Research Personality: Putrajaya Hospital – Dr. Zanariah Hussein Malaysia’s Endocrine Centre Consultant Endocrinologist and Physician Hospital Putrajaya Working with CRM to move Malaysia forward When passion drives research: Pragmatic approach to cluster Greentown Health Clinic randomized trials ABOUT CLINICAL RESEARCH MALAYSIA Clinical Research Malaysia (CRM) is a non-prot company wholly owned by the Government of Malaysia’s Ministry of Health. CRM was established in June 2012 to position Malaysia as a preferred global destination for industry-sponsored research (ISR) and to function as an enabler and facilitator to the industry and medical fraternity. By working with other stakeholders, CRM strives to improve the local ecosystem to support growth in ISR, facilitate the needs and requirements of industry players, grow the pool of capable investigators, support staff and trial sites, and improve their capabilities and capacities to conduct ISR. With the Ministry of Health’s backing and clear knowledge of the local research environment, CRM is able to provide sponsors (primarily from the pharmaceutical, biotech and medical device industries) and contract research organizations (CRO) with an extensive range of services that includes feasibility studies, investigator selection, placement and development of study coordinators, management of trial budget, review of clinical trial agreements and updates on local laws, guidelines and regulations. CRM also undertakes marketing and promotional activities to build industry awareness about the opportunities for ISR in Malaysia, and create public and patient awareness of clinical trials. 1 CONTENTS From the CEO’s desk 3 Malaysia’s ISR Statistics (Jan– Oct ’15) 4 Medical Research and Ethics Committee (MREC) Updates 6 Research Personality Dr.
  • Malaysian Journal of Pharmacy Vol.4 Issue 1, July 2018 ______

    Malaysian Journal of Pharmacy Vol.4 Issue 1, July 2018 ______

    Vol. 2 Issue 2. August 2016 Vol.4 Issue 1. July 2018 MALAYSIANMALAYSIAN JOURNALJOURNALof ofPHARMACY PHARMACY Supplement: Proceedingsofthe9th National Pharmacy R&D In this issue:Conference 2016 Serial Drama: Seven Steps to Avoid Falling Foul of Falsified Medicines Directive (FMD) Management of Mild Valproic Acid Toxicity with Hemodialysis – A Case Report Stability of Extemporaneously Compounded Chloral Hydrate Oral Solution Supplement Proceedings of the 10th National Pharmacy R&D Conference 2018 APublicationoftheMalaysianPharmaceuticalSociety EDITORIAL BOARD A Publication of the Malaysian Pharmaceutical Society Malaysian Journal of Pharmacy Vol.4 Issue 1, July 2018 ___________________________________________________________________ The Official Journal of the Malaysian Pharmaceutical Society Editor-in-Chief: Assoc. Prof. Dr. Asrul Akmal Shafie Managing Editor: Mr. Ho Rhu Yann International Advisory Board: Assoc. Prof. Dr. Chua Siew Siang Prof. Dr. Mohd Baidi Bahari Associate Editors: Mr. Lam Kai Kun Prof. Dr. Mohamed Azmi Ahmad Hassali Assoc. Prof. Dr. Mohamad Haniki Nik Mohamed Ms. Syireen Alwi Prof. P T Thomas Dr. Wong Tin Wui Assoc. Prof. Dr. Vikneswaran a/l Murugaiyah Prof. Dr. Yuen Kah Hay Publisher: Malaysian Pharmaceutical Society 16-2 Jalan OP 1/5, 1-Puchong Business Park Off Jalan Puchong 47160 Puchong Malaysia Tel: 6-03-80791861 Fax: 6-03-80700388 Homepage: www.mps.org.my Email: [email protected] The Malaysian Journal of Pharmacy is a publication of the Malaysian Pharmaceutical Society. Enquiries are to be directed to the publisher at the above address. The Publisher reserves copy- right and renewal on all published materials, and such material may not be reproduced in any form without the written permission of the Publisher.
  • Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension

    Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension

    ORIGINAL ARTICLE Cardiovascular Disorders http://dx.doi.org/10.3346/jkms.2015.30.10.1429 • J Korean Med Sci 2015; 30: 1429-1438 Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension Wook-Jin Chung,1* Yong Bum Park,2* Despite recent advances in understanding of the pathobiology and targeted treatments of Chan Hong Jeon,3* Jo Won Jung,4* pulmonary arterial hypertension (PAH), epidemiologic data from large populations have Kwang-Phil Ko,5 Sung Jae Choi,6 been limited to western countries. The aim of the Korean Registry of Pulmonary Arterial Hye Sun Seo,7 Jae Seung Lee,8 Hypertension (KORPAH) was to examine the epidemiology and prognosis of Korean 9 Hae Ok Jung, and KORPAH Investigators patients with PAH. KORPAH was designed as a nationwide, multicenter, prospective data collection using an internet webserver from September 2008 to December 2011. A total of 1Department of Cardiovascular Medicine, Gachon Cardiovascular Research Institute, Gachon 625 patients were enrolled. The patients’ mean age was 47.6 ± 15.7 yr, and 503 (80.5%) University Gil Medical Center, Incheon; 2Division of were women. The diagnostic methods included right heart catheterization (n = 249, Pulmonology, Department of Internal Medicine, 39.8%) and Doppler echocardiography (n = 376, 60.2%). The etiologies, in order of Hallym University Gangdong Sacred Heart Hospital, frequency, were connective tissue disease (CTD), congenital heart disease, and idiopathic Seoul; 3Division of Rheumatology, Department of Internal Medicine, Soonchunhyang University PAH (IPAH) (49.8%, 25.4%, and 23.2%, respectively). Patients with WHO functional class Hospital, Bucheon; 4Division of Pediatric Cardiology, III or IV at diagnosis were 43.4%.
  • 2014/15 Knowledge Sharing Program with Mexico: Enhancing Innovation Capacities for Sustainable Development of the Mexican Economy Www

    2014/15 Knowledge Sharing Program with Mexico: Enhancing Innovation Capacities for Sustainable Development of the Mexican Economy Www

    2014/15 Knowledge Sharing Program with Mexico Sharing Program 2014/15 Knowledge 2014/15 Knowledge Sharing Program with Mexico: Enhancing Innovation Capacities for Sustainable Development of the Mexican Economy .go.kr ksp www. Ministry of Strategy and Finance Government Complex-Sejong, 477, Galmae-ro, Sejong Special Self-Governing City 30109, Korea Tel. 82-44-215-7762 www.mosf.go.kr Korea Development Institute 263 Namsejong-ro, Sejong Special Self-Governing City 30149, Korea Tel. 82-44-550-4114 www.kdi.re.kr Knowledge Sharing Program www.ksp.go.kr Center for International Development, KDI ISBN 978-89-8063-941-0 MINISTRY OF STRATEGY ISBN 978-89-8063-827-7(set) cid.kdi.re.kr AND FINANCE 2014/15 Knowledge Sharing Program with Mexico: Enhancing Innovation Capacities for Sustainable Development of the Mexican Economy 2014/15 Knowledge Sharing Program with Mexico Project Title Enhancing Innovation Capacities for Sustainable Development of the Mexican Economy Prepared by Korea Development Institute (KDI) Supported by Ministry of Strategy and Finance (MOSF), Republic of Korea Prepared for Government of the United Mexican States In Cooperation with Mexican Agency for International Development Cooperation Program Directors Siwook Lee, Executive Director, Center for International Development (CID), KDI Hong Tack Chun, Dean of KDI School of Public Policy and Management, Former Executive Director, CID, KDI Taihee Lee, Director, Center for International Development (CID), KDI Program Officer Hyun Jeong Park, Research Associate, Division of Policy Planning & Consultation, KDI Senior Advisor Young Ju Kim, Former Minister of Commerce, Industry and Energy, Republic of Korea Project Manager Taihee Lee, Director, Center for International Development (CID), KDI Authors Chapter 1.
  • Fever Phobia in Korean Caregivers and Its Clinical Implications

    Fever Phobia in Korean Caregivers and Its Clinical Implications

    ORIGINAL ARTICLE Pediatrics http://dx.doi.org/10.3346/jkms.2013.28.11.1639 • J Korean Med Sci 2013; 28: 1639-1644 Fever Phobia in Korean Caregivers and Its Clinical Implications Young Ho Kwak,1 Do Kyun Kim,1 Fever is the most common complaint among children brought into the emergency Hye Young Jang,2 Jin Joo Kim,3 department (ED). ‘Fever phobia’ is a descriptive term for an unrealistic concern about the Jeong-Min Ryu,4 Seong Beom Oh,5 consequences of fever. ‘Fever phobia’ is prevalent among parents and even healthcare Eui Jung Lee,1,6 Ji Sook Lee,7 providers, worldwide. The aim of this study was to determine the implications of fever- 8 9 Jin Hee Lee, Jin Hee Jung, phobic ideas in Korean caregivers. A prospective, multi-center survey was conducted on 10 and Seung Baik Han Korean caregivers who visited the EDs with febrile children. In total, 746 caregivers were enrolled. The mean age of the subjects was 34.7 yr (SD ± 5.0). Three hundred sixty 1Department of Emergency Medicine, Seoul National University College of Medicine, Seoul; respondents (48.3%) believed that the body temperature of febrile children can reach 2Department of Emergency Medicine, higher than 42.0°C. Unrealistic concerns about the improbable complications of fever, Soonchunhyang University Seoul Hospital, Seoul; such as brain damage, unconsciousness, and loss of hearing/vision were believed by 295 3 Department of Emergency Medicine, Gachon (39.5%), 66 (8.8%), and 58 (7.8%) caregivers, respectively. Four hundred ninety-four University Gil Hospital, Incheon; 4Pediatric Emergency Center, Department of Emergency (66.2%) guardians woke children to give antipyretics.
  • National Heart Association of Malaysia

    National Heart Association of Malaysia

    National Heart Association of Malaysia YIA 1 YIA 2 SUBCLINICAL MYOCARDIAL DIASTOLIC DYSFUNCTION IN IMPACT OF PRE-OPERATIVE ASSESSMENT OF MYOCARDIAL PATIENTS WITH HIGH C-REACTIVE PROTEIN ASYMPTOMATIC VIABILITY USING CMR VS ECHOCARDIOGRAPHY ALONE ON 1 SYSTEMIC LUPUS ERYTHEMATOSUS IN ASIAN POPULATION YEAR SURVIVAL AND EF IN PATIENTS WITH POOR LV FUNCTION Tan SK1, Teh CL2, Chua SK1, Yew KL1, Nor Hanim1, Chang BC1, Alan FYY1, Annuar R3Ong TK1, UNDERGOING CABG Sim KH1 Nor Hanim MA1, R Annuar2, BC Chang1, SK Chua1, Fong AYY1, KL Yew1, NZ Kiew1, YL Cham1, 1Department of Cardiology, Sarawak General Hospital 2Rheumatology Unit, Sarawak General Hospital Ong TK1 , KH Sim1 3Universiti Sarawak Malaysia (UNIMAS) 1 Cardiology Department, Sarawak General Hospital, 2Universiti Malaysia Sarawak.(UNIMAS) Sarawak, Malaysia. BACKGROUND Systemic lupus erythematosus (SLE) causes significant vascular, myocardial and pericardial inflammation leading to significant cardiovascular morbidity and mortality. Serum C-Reactive BACKGROUND: Patients with poor left ventricular (LV) function have poorer outcome after coronary Protein (CRP) level parallels with inflammatory state in rheumatoid arthritis. However, CRP response in artery bypass grafting (CABG). The adjunctive use of late gadolinium enhanced cardiac MRI (CMR) to SLE inflammatory state is different. assess myocardial viability may be a better strategy than using echocardiography alone. OBJECTIVE To determine subclinical myocardial diastolic dysfunction in asymptomatic SLE Asian OBJECTIVE: To compare 1 year survival and change in LV ejection fraction (LVEF) in CABG patients patients and its relation to CRP. with and without a viability study METHOLOGY This is a prospective cohort study. 68 Asian patients with confirmed diagnosis of SLE in inactive stage, no known coronary artery disease or lung disease and not in heart failure undergone METHODS AND MATERIALS:: This is a retrospective study of all CABG patients in Sarawak General standard transthoracic echocardiography and tissue Doppler imaging.
  • University Name

    University Name

    GENERAL INFORMATION University Name Soonchunhyang University Korean - http://www.sch.ac.kr/ University Website English - http://home.sch.ac.kr/english/index.jsp Specific Exchange Website http://sgee.sch.ac.kr/asia/ Soonchunhyang University Center for Global Education & Exchange BRIX BI301 Exchange Program Address 22-9 Soonchunhyang-ro, Shinchang-myun (International Office) Asan-si, Chungnam, South Korea (Postal Code: 31538) Tel: +82 41 530 1383 Fax: +82 41 530 1381 Email: [email protected] Asan City, Chungnam Province University Location Population of City: 300,000 Closest Major Cities: 30km to Cheonan, 100km to Seoul(Capital) INTERNATIONAL OFFICE CONTACT INFORMATION Study Abroad Program Coordinator LEE, Suejung (Ms.) International Relations +82 41 530 1305 [email protected] International Studies Coordinator Kim, John(Mr.) Incoming Students +82 41 530 1383 [email protected] Study Abroad Program Advisor Derek Stubenberg (Mr.) Outgoing Students +82 10 9027 9809 [email protected] ACADEMIC INFORMATION Spring 2021 Semester - Application Deadline: November 1, 2020 - Semester usually from March to Mid of June (A total of 16 weeks) Academic Calendar Fall 2021 Semester http://sgee.sch.ac.kr/asia/su - Application Deadline: April 25, 2021 b02/sub_05_01.php - Semester starts from September to Mid of December (A total of 16 weeks) Exams Mid-term exams in the 8th week of each semester Final exams at the end of each semester Orientation Session Students are recommended to arrive on the official arrival days, which is approximately one week before the start of the semester. Orientation is mandatory for all exchange students. Orientation generally takes place on the Thursday and Friday before the start of the semester.
  • Comparison of the Treatment Practice and Hospitalization Cost Of

    Comparison of the Treatment Practice and Hospitalization Cost Of

    RESEARCH ARTICLE Comparison of the treatment practice and hospitalization cost of percutaneous coronary intervention between a teaching hospital and a general hospital in Malaysia: A cross sectional study Kun Yun Lee1*, Wan Azman Wan Ahmad2, Ee Vien Low3, Siow Yen Liau4,5, a1111111111 Lawrence Anchah6, Syuhada Hamzah7, Houng-Bang Liew5,8, Rosli B. Mohd Ali9, a1111111111 Omar Ismail10, Tiong Kiam Ong11, Mas Ayu Said1, Maznah Dahlui1 a1111111111 1 Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, a1111111111 Malaysia, 2 Division of Cardiology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala a1111111111 Lumpur, Malaysia, 3 Pharmaceutical Services Division, Ministry of Health, Selangor, Malaysia, 4 Department of Pharmacy, Queen Elizabeth 2 Hospital, Sabah, Malaysia, 5 Clinical Research Centre, Queen Elizabeth 2 Hospital, Sabah, Malaysia, 6 Department of Pharmacy, Sarawak General Hospital Heart Centre, Sarawak, Malaysia, 7 Administrative Office, Penang General Hospital, Penang, Malaysia, 8 Division of Cardiology, Queen Elizabeth 2 Hospital, Sabah, Malaysia, 9 Department of Cardiology, National Heart Institute, Kuala Lumpur, Malaysia, 10 Division of Cardiology, Penang General Hospital, Penang, Malaysia, 11 Department of OPEN ACCESS Cardiology, Sarawak General Hospital Heart Centre, Sarawak, Malaysia Citation: Lee KY, Wan Ahmad WA, Low EV, Liau SY, Anchah L, Hamzah S, et al. (2017) Comparison * [email protected] of the treatment practice and hospitalization cost of percutaneous coronary intervention between a teaching hospital and a general hospital in Abstract Malaysia: A cross sectional study. PLoS ONE 12 (9): e0184410. https://doi.org/10.1371/journal. pone.0184410 Editor: Yoshihiro Fukumoto, Kurume University Introduction School of Medicine, JAPAN The increasing disease burden of coronary artery disease (CAD) calls for sustainable car- Received: May 15, 2017 diac service.
  • Improved Regional Disparities in Neonatal Care by Government-Led

    Improved Regional Disparities in Neonatal Care by Government-Led

    J Korean Med Sci. 2018 Feb 5;33(6):e43 https://doi.org/10.3346/jkms.2018.33.e43 eISSN 1598-6357·pISSN 1011-8934 Original Article Improved Regional Disparities in Pediatrics Neonatal Care by Government-led Policies in Korea In Gyu Song ,1 Seung Han Shin ,2 and Han-Suk Kim 2 1Department of Pediatrics, Kyung Hee University Medical Center, Seoul, Korea 2Department of Pediatrics, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea Received: Aug 22, 2017 ABSTRACT Accepted: Nov 13, 2017 Background: Address for Correspondence: Although the number of high-risk neonates has increased in Korea, hospitals Seung Han Shin, MD were reluctant to open or maintain neonatal intensive care unit (NICU) due to the low Department of Pediatrics, Seoul National medical cost. Consequently, there were regional disparities in facilities, equipment, and University Hospital, Seoul National University neonatal health outcomes. For these reasons, the Korean government began to invest in College of Medicine, 101 Daehak-ro, neonatal care during the last decade. We identified the status of NICUs in Korea and assessed Jongno-gu, Seoul 03080, Korea. changes after the government-driven policies. E-mail: [email protected] Methods: We surveyed 87 of 89 hospitals that operated NICUs in 2015. The questionnaire © 2018 The Korean Academy of Medical assessed the number of NICU beds, admission and mortality rates of very low birthweight Sciences. infants (VLBWIs), personnel status, equipment and facilities, and available multidisciplinary This is an Open Access article distributed approach. Current data was compared with the previous studies and changes in the status under the terms of the Creative Commons Attribution Non-Commercial License (https:// and function of the nationwide NICU from 2009 and 2011.